Keyphrases
Purpura
100%
Steroid Resistance
100%
Azathioprine Therapy
100%
Disease-modifying Antirheumatic Drugs (DMARDs)
37%
Corticosteroids
25%
Renal Involvement
25%
Histology
12%
Adverse Events
12%
Therapeutic Potential
12%
Corticosteroid Use
12%
Corticosteroid Therapy
12%
Cutaneous Vasculitis
12%
Purpura Nephritis
12%
Early Discontinuation
12%
Classification Criteria
12%
Refractory Cases
12%
Chronic Form
12%
Medicine and Dentistry
Azathioprine
100%
Purpura
100%
Disease-Modifying Antirheumatic Drug
22%
Adverse Event
11%
Biological Product
11%
Corticosteroid Therapy
11%
Nephritic Syndrome
11%
Case Presentation
11%
Hypersensitivity Angiitis
11%
Disease Modifying Antirheumatic Drug
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Azathioprine
100%
Purpura
100%
Disease Modifying Antirheumatic Drug
11%
Adverse Event
11%
Biological Product
11%
Nephritis
11%
Leukocytoclastic Vasculitis
11%
Diseases
11%